Clinical-stage United States

Androclus is developing epitope-specific immunotherapy as a breakthrough technology for the treatment of autoimmune diseases. The proprietary technology platform is based on identification of compounds with specific immunomodulatory activity. In contrast ...

Alacrity Biosciences is committed to bringing to market unique and proprietary products to treat ophthalmic diseases. Our approach is to develop compounds with unique mechanisms of action to fulfill unmet needs and/or compliment existing therapeutic modalities ...

ACCESS Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and marketing novel therapeutics for cancer and related conditions. ACCESS has built a portfolio of proprietary anti-cancer product candidates through the in-licensing ...

OxThera is a clinical stage biotechnology company with its first product in phase III. The company is based in Sweden (Uppsala) and Florida (Gainesville). The company develops products, based on its cell- and enzyme based proprietary technologies, for ...

American BioHealth Group LLC, is a clinical stage pharmaceutical company located in San Diego, California. Our target market is individuals wishing to help prevent acute hearing loss or tinnitus (ringing in the ears), those seeking aids in treatment immediately ...

Sirna Therapeutics is a clinical-stage biotechnology company developing RNAi-based therapies for serious diseases and conditions, including age- related macular degeneration (AMD), hepatitis B and C, dermatology, asthma, Huntington's Disease, diabetes ...

InteKrin Therapeutics, Inc. is a privately-held biopharmaceutical company based in Los Altos, CA pursuing the clinical development of therapeutics for diabetes, obesity and metabolic disorders. The company focuses on high value therapeutics addressing ...

Zelos Therapeutics specializes in the development of innovative treatments for bone disorders and related indications in large, underserved markets. Led by an experienced team of biopharmaceutical executives and funded by leading health care investors ...

BioXell SpA is an Italy-based biopharmaceutical company. The Company focuses on the research, development and commercialization of therapies for various medical needs. It is active in a range of therapeutic areas, such as urology (benign prostatic hyperplasia ...

Cougar Biotechnology, Inc. is a development-stage biopharmaceutical company that acquires and develops products for the treatment of cancer. The Company focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical ...

Zelos Therapeutics specializes in the development of innovative treatments for bone disorders and related indications in large, underserved markets. Led by an experienced team of biopharmaceutical executives and funded by leading health care investors ...

Zelos Therapeutics specializes in the development of innovative treatments for bone disorders and related indications in large, underserved markets. Led by an experienced team of biopharmaceutical executives and funded by leading health care investors ...

" Neuronetics is focused on successfully developing and commercializing noninvasive therapies to treat significant, chronic psychiatric and neurological disorders. We are committed to working collaboratively with the clinical community to improve care ...

Sequella is a clinical stage biopharmaceutical company focused on commercializing improved treatment paradigms for diseases of epidemic potential. The company leverages its global influence, R&D platforms and infectious disease expertise to proactively ...

Humanetics Corporation is a clinical-stage pharmaceutical company engaged in accelerated discovery, development and commercialization of proprietary drugs in markets with urgent and unmet needs. With a focus on non-synthetic, orally-administered, bioactive ...

BioXell SpA is an Italy-based biopharmaceutical company. The Company focuses on the research, development and commercialization of therapies for various medical needs. It is active in a range of therapeutic areas, such as urology (benign prostatic hyperplasia ...

Santaris Pharma is a pioneer in the field of oligonucleotide drugs based on the third generation RNA chemistry, Locked Nucleic Acid (LNA), to which the company holds worldwide exclusive rights in therapeutics. Amongst several unique features, the LNA chemistry ...

Transport Pharmaceuticals, Inc., is a privately held, clinical-stage specialty pharmaceutical company revolutionizing the treatment of dermal diseases by bringing together cutting-edge medical electronics, drug formulation and materials science to develop ...

Cara Therapeutics is an emerging biotechnology company focused on developing novel therapeutics to treat human diseases associated with pain and inflammation. Cara possesses both near-term clinical development opportunities combined with proprietary approaches ...

AlphaVax is developing a new vaccine technology with broad applications against infectious disease, cancer and biodefense threats which has the potential to redefine vaccines and the role they play in medicine. AlphaVax uses a specialized viral vector ...

Melior Discovery is dedicated to uncovering new therapeutic applications for partners' existing drugs. By utilizing the unique and highly efficient theraTRACESM indications discovery platform, Melior can systematically study a single compound in multiple ...

ACCESS Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and marketing novel therapeutics for cancer and related conditions. ACCESS has built a portfolio of proprietary anti-cancer product candidates through the in-licensing ...

NovaBay Pharnaceuticals, Inc. (NovaBay) is a clinical stage biopharmaceutical company focused on developing product candidates for the treatment or prevention of different infections in hospital and non-hospital environments. The Company has discovered ...

Acucela Inc. is a clinical stage biotech company discovering new drug therapies for eye diseases. Neurodegenerative retinal diseases such as macular degeneration, Stargardt's disease, retinitis pigmentosa and glaucoma, significantly affect quality of life ...

Founded in late 2002, Acuity Pharmaceuticals is a product-focused pharmaceutical firm that is a pioneer in commercializing small interfering RNA (siRNA) therapeutics. Acuity is developing treatments for serious diseases of the eye and retina -- age-related ...